Innogen Pharmaceuticals Receives PIC/S GMP Certificatation, Accelerating Global Expansion of Efsubaglutide Alfa

RegulatoryapprovedEfsubaglutide alfaPositive

AI Analysis

Summary

Innogen Pharmaceuticals announced that its Efsubaglutide alfa manufacturing facility in Suzhou has received PIC/S GMP Certification, supporting the company's global expansion efforts in metabolic disease treatment.

Outcome Details

PIC/S GMP Certification received for manufacturing facility in Suzhou

Importance:6/10

Sentiment:

0.70

manufacturingGMP certificationglobal expansionChinametabolic diseases

Related Companies

$GBCYD

Read the original article

Published by PR Newswire Clinical Trials on August 4, 2026 5:25 AM

Read Original